Calcium-Sensing Receptor Antagonist NPS-2143 Inhibits Breast Cancer cell Proliferation, Migration and Invasion via Downregulation of p-ERK1/2, Bcl-2 and Integrin β1 and Induces Caspase 3/7 Activation

Purpose: Calcium-sensing receptor (CaSR) has been associated with breast cancer metastasis tothe bone. Targeting chemoattractant factors, such as calcium, that are released in response tobone resorption could prevent metastasis and induce apoptosis of cancer cells. In the presentstudy, we investigat...

Full description

Bibliographic Details
Main Authors: Mohammad A.Y. Alqudah, Marwah Azaizeh, Aref Zayed, Leen Asaad
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2022-03-01
Series:Advanced Pharmaceutical Bulletin
Subjects:
Online Access:https://apb.tbzmed.ac.ir/PDF/apb-12-383.pdf
_version_ 1818017488260038656
author Mohammad A.Y. Alqudah
Marwah Azaizeh
Aref Zayed
Leen Asaad
author_facet Mohammad A.Y. Alqudah
Marwah Azaizeh
Aref Zayed
Leen Asaad
author_sort Mohammad A.Y. Alqudah
collection DOAJ
description Purpose: Calcium-sensing receptor (CaSR) has been associated with breast cancer metastasis tothe bone. Targeting chemoattractant factors, such as calcium, that are released in response tobone resorption could prevent metastasis and induce apoptosis of cancer cells. In the presentstudy, we investigated the potential caspase 3/7 activation following treatment with a CaSRantagonist, NPS-2143, in breast cancer cells. In addition, the effects of NPS-2143 on breastcancer cell proliferation, migration and invasion were assessed.Methods: Colorimetric MTT assay was used to evaluate cell viability. Apo-one homogeneouscaspase-3/7 assay was used to measure caspase 3/7 activities in breast cancer cells. Cellmigration and invasion were assessed using scratch wound assay and matrigel invasionchambers, respectively. The protein expressions of p-ERK1/2, integrin β1 and Bcl-2 wereevaluated using western blotting.Results: Our study revealed that NPS-2143 significantly reduced cell proliferation with halfmaximal (50%) inhibitory concentration (IC50) values of 4.08 and 5.71 μM in MDA-MB-231and MCF-7 cells, respectively. NPS-2143 induced caspase 3/7 activation in MDA-MB-231 breastcancer cells which was accompanied with a remarkable reduction in the expression of Bcl-2antiapoptotic protein. NPS-2143 suppressed migratory and invasive abilities of MDA-MB-231cells with a significant reduction in the expression of p-ERK1/2 and integrin β1 proteins.Conclusion: Our study confirms the ability NPS-2143 to suppress proliferative, migratory andinvasive effects of breast cancer cells which was accompanied by caspase 3/7 activation andsuggests the potential of NPS-2143 as a promising anti-cancer molecule in breast cancer.
first_indexed 2024-04-14T07:26:47Z
format Article
id doaj.art-c234e649324f4922a9ecf9943ddc2dd5
institution Directory Open Access Journal
issn 2228-5881
2251-7308
language English
last_indexed 2024-04-14T07:26:47Z
publishDate 2022-03-01
publisher Tabriz University of Medical Sciences
record_format Article
series Advanced Pharmaceutical Bulletin
spelling doaj.art-c234e649324f4922a9ecf9943ddc2dd52022-12-22T02:05:59ZengTabriz University of Medical SciencesAdvanced Pharmaceutical Bulletin2228-58812251-73082022-03-0112238338810.34172/apb.2022.037apb-30398Calcium-Sensing Receptor Antagonist NPS-2143 Inhibits Breast Cancer cell Proliferation, Migration and Invasion via Downregulation of p-ERK1/2, Bcl-2 and Integrin β1 and Induces Caspase 3/7 ActivationMohammad A.Y. Alqudah0Marwah Azaizeh1Aref Zayed2Leen Asaad3Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.Department of Medicinal Chemistry and Pharmacognosy, Jordan University of Science and Technology, Irbid, Jordan.Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.Purpose: Calcium-sensing receptor (CaSR) has been associated with breast cancer metastasis tothe bone. Targeting chemoattractant factors, such as calcium, that are released in response tobone resorption could prevent metastasis and induce apoptosis of cancer cells. In the presentstudy, we investigated the potential caspase 3/7 activation following treatment with a CaSRantagonist, NPS-2143, in breast cancer cells. In addition, the effects of NPS-2143 on breastcancer cell proliferation, migration and invasion were assessed.Methods: Colorimetric MTT assay was used to evaluate cell viability. Apo-one homogeneouscaspase-3/7 assay was used to measure caspase 3/7 activities in breast cancer cells. Cellmigration and invasion were assessed using scratch wound assay and matrigel invasionchambers, respectively. The protein expressions of p-ERK1/2, integrin β1 and Bcl-2 wereevaluated using western blotting.Results: Our study revealed that NPS-2143 significantly reduced cell proliferation with halfmaximal (50%) inhibitory concentration (IC50) values of 4.08 and 5.71 μM in MDA-MB-231and MCF-7 cells, respectively. NPS-2143 induced caspase 3/7 activation in MDA-MB-231 breastcancer cells which was accompanied with a remarkable reduction in the expression of Bcl-2antiapoptotic protein. NPS-2143 suppressed migratory and invasive abilities of MDA-MB-231cells with a significant reduction in the expression of p-ERK1/2 and integrin β1 proteins.Conclusion: Our study confirms the ability NPS-2143 to suppress proliferative, migratory andinvasive effects of breast cancer cells which was accompanied by caspase 3/7 activation andsuggests the potential of NPS-2143 as a promising anti-cancer molecule in breast cancer.https://apb.tbzmed.ac.ir/PDF/apb-12-383.pdfbreast cancercalcium-sensing receptornps-2143caspase 3/7proliferationinvasion
spellingShingle Mohammad A.Y. Alqudah
Marwah Azaizeh
Aref Zayed
Leen Asaad
Calcium-Sensing Receptor Antagonist NPS-2143 Inhibits Breast Cancer cell Proliferation, Migration and Invasion via Downregulation of p-ERK1/2, Bcl-2 and Integrin β1 and Induces Caspase 3/7 Activation
Advanced Pharmaceutical Bulletin
breast cancer
calcium-sensing receptor
nps-2143
caspase 3/7
proliferation
invasion
title Calcium-Sensing Receptor Antagonist NPS-2143 Inhibits Breast Cancer cell Proliferation, Migration and Invasion via Downregulation of p-ERK1/2, Bcl-2 and Integrin β1 and Induces Caspase 3/7 Activation
title_full Calcium-Sensing Receptor Antagonist NPS-2143 Inhibits Breast Cancer cell Proliferation, Migration and Invasion via Downregulation of p-ERK1/2, Bcl-2 and Integrin β1 and Induces Caspase 3/7 Activation
title_fullStr Calcium-Sensing Receptor Antagonist NPS-2143 Inhibits Breast Cancer cell Proliferation, Migration and Invasion via Downregulation of p-ERK1/2, Bcl-2 and Integrin β1 and Induces Caspase 3/7 Activation
title_full_unstemmed Calcium-Sensing Receptor Antagonist NPS-2143 Inhibits Breast Cancer cell Proliferation, Migration and Invasion via Downregulation of p-ERK1/2, Bcl-2 and Integrin β1 and Induces Caspase 3/7 Activation
title_short Calcium-Sensing Receptor Antagonist NPS-2143 Inhibits Breast Cancer cell Proliferation, Migration and Invasion via Downregulation of p-ERK1/2, Bcl-2 and Integrin β1 and Induces Caspase 3/7 Activation
title_sort calcium sensing receptor antagonist nps 2143 inhibits breast cancer cell proliferation migration and invasion via downregulation of p erk1 2 bcl 2 and integrin β1 and induces caspase 3 7 activation
topic breast cancer
calcium-sensing receptor
nps-2143
caspase 3/7
proliferation
invasion
url https://apb.tbzmed.ac.ir/PDF/apb-12-383.pdf
work_keys_str_mv AT mohammadayalqudah calciumsensingreceptorantagonistnps2143inhibitsbreastcancercellproliferationmigrationandinvasionviadownregulationofperk12bcl2andintegrinb1andinducescaspase37activation
AT marwahazaizeh calciumsensingreceptorantagonistnps2143inhibitsbreastcancercellproliferationmigrationandinvasionviadownregulationofperk12bcl2andintegrinb1andinducescaspase37activation
AT arefzayed calciumsensingreceptorantagonistnps2143inhibitsbreastcancercellproliferationmigrationandinvasionviadownregulationofperk12bcl2andintegrinb1andinducescaspase37activation
AT leenasaad calciumsensingreceptorantagonistnps2143inhibitsbreastcancercellproliferationmigrationandinvasionviadownregulationofperk12bcl2andintegrinb1andinducescaspase37activation